The Sugar Daddy Effect? Assessing Corporate venture capital, Sovereign funds and Green Energy!
Musings on Markets
OCTOBER 28, 2024
Arguably, this is the prime rationale for the growing venture capital arms at pharmaceutical companies, with almost $30 billion invested in biopharma ventures just in 2022. Asia has the largest number of sovereign wealth funds, but the funds from the Gulf/Middle East are among the largest, in terms of funding at their disposal.
Let's personalize your content